Revolution Medicines (RVMD) Total Liabilities (2018 - 2026)

Revolution Medicines' Total Liabilities history runs 9 years deep, the most recent figure standing at $753.8 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 162.47% year-over-year to $753.8 million; the TTM figure through Mar 2026 stood at $753.8 million (up 162.47% YoY), while the FY2025 annual figure was $723.2 million, up 146.75% from the prior year.
• Total Liabilities was $753.8 million for Q1 2026 at Revolution Medicines, up from $723.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $753.8 million in Q1 2026 to a low of $121.0 million in Q1 2023.
• Historically, Total Liabilities has averaged $295.8 million across 5 years, with a median of $189.6 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Total Liabilities slipped 8.16% in 2023, then soared 233.01% in 2025.
• A 5-year view of Total Liabilities shows it stood at $126.7 million in 2022, then jumped by 85.82% to $235.5 million in 2023, then gained by 24.45% to $293.1 million in 2024, then jumped by 146.75% to $723.2 million in 2025, then climbed by 4.23% to $753.8 million in 2026.
• The last three Total Liabilities figures came in at $753.8 million (Q1 2026), $723.2 million (Q4 2025), and $655.0 million (Q3 2025), per Business Quant data.